Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Amino Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114605458A details a novel Rh-catalyzed C-C bond activation method for high-purity chiral intermediates, offering significant cost reduction in API manufacturing.
Patent CN113896662A details a high-yield rhodium-catalyzed synthesis for chiral aminocyclopropane intermediates, offering significant cost and supply chain advantages.
Patent CN106397239B reveals advanced amino acid ester ionic liquid synthesis offering high stereoselectivity and scalable green manufacturing solutions.
Patent CN1119321C details a scalable Reformatsky route for ethyl 3S-amino-4-pentynoate, offering high optical purity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN102212041A details a cost-effective synthesis of chiral cyclic beta-amino aryl butyric acid derivatives with high optical purity suitable for pharmaceutical manufacturing.
Patent CN107445894B reveals a room-temperature synthesis of chiral cyclopropyl amino acids using cesium carbonate, offering high purity and simplified processing for pharmaceutical intermediate supply chains.
Patent CN113072456A details a novel copper-catalyzed asymmetric difluoromethylation for high-purity pharmaceutical intermediates, offering significant cost and supply chain advantages.
Patent CN102212015A details a cost-effective chiral induction method for high-purity beta-amino acids, offering significant supply chain advantages for API manufacturing.
Patent CN102643236A details a green synthesis of chiral imidazolium ionic liquids from natural amino acids, offering high purity and cost-effective manufacturing solutions.
Novel chiral Brønsted acid catalysis method for unnatural serine. Reduces cost and improves supply chain reliability for pharmaceutical intermediate manufacturing globally.
Patent CN112279743B details a novel iridium-catalyzed asymmetric hydrogenation method for chiral alpha-amino acid esters, offering high enantioselectivity and industrial scalability for pharmaceutical intermediates.
Patent CN111285768B introduces a recyclable polyionic liquid copper catalyst for efficient asymmetric Henry reactions in water, offering significant cost reduction in chiral catalyst manufacturing.
Patent CN103429567A details a mild Rh-catalyzed process for chiral amino acids with >98% ee. Ideal for reliable pharmaceutical intermediate supply chains.
Patent CN113582865A details a novel copper-catalyzed route for alpha,alpha-disubstituted chiral amino acid esters, offering high enantioselectivity and streamlined manufacturing for API intermediates.
Novel synthesis of chiral optical pure alkynylamide substituted α,β-diamino acid derivatives via Rh-catalyzed three-component reaction for potent anticancer applications.
Novel patent CN121342695A offers scalable chiral amino acid synthesis. Reduces waste and cost for IL-17 inhibitor intermediates. Reliable supply chain partner.
Novel Ni-catalyzed asymmetric synthesis offers high yield and enantioselectivity for pharmaceutical intermediates, ensuring supply chain stability.
Novel cesium carbonate catalyzed method for high-purity chiral cyclopropyl amino acid. Reduces steps and solvent use for reliable pharmaceutical intermediate supply.
Novel Ni-catalyzed asymmetric method for chiral quaternary carbon alpha-amino acid esters. High yield, excellent ee, scalable process for API intermediates.
High-yield, high-ee synthesis of non-natural amino acids with water as proton source. Reduce production costs and supply chain risks for API manufacturing.